Stay updated on Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:53:46.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:42:23.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:57:31.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    - Removed the topic tags 'Prostate cancer' and the related topic 'MedlinePlus Genetics' from the study's metadata.
    Difference
    0.2%
    Check dated 2026-03-04T12:32:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics appear as related topics on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T06:49:42.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The notice about government funding lapse and Revision: v3.4.1 were removed.
    Difference
    0.5%
    Check dated 2026-02-11T04:42:54.000Z thumbnail image

Stay in the know with updates to Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prohibitin Peptide 1 in Metastatic Prostate Cancer Clinical Trial page.